ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 106

$1.57M Total Retail Price of All Prescriptions

Rank: 1 out of 106

394 Patients Receiving at Least One Drug in Part D
30%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

24% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

69% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 1,608 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$177 was the average price of a prescription from this provider, compared to $122 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SUBOXONE 1,080 205 10 1 18
SERTRALINE HCL 372 72 2 31
TRAZODONE HCL 342 84 3 43
LAMOTRIGINE 299 28 4 22
HYDROCODONE-ACETAMINOPHEN 264 68 S3 5 1
VENLAFAXINE HCL ER 258 88 6 60
PROPRANOLOL HCL 225 27 7 69
TIZANIDINE HCL 205 44 8 61
BUPRENORPHINE HCL 200 44 S3 10 9 146
TOPIRAMATE 188 17 10 32
OMEPRAZOLE 174 12 11 3
PROMETHAZINE HCL 147 0 R 12 140
RISPERIDONE 146 19 13 81
ZOLPIDEM TARTRATE 136 18 14 29
FLUOXETINE HCL 131 21 15 67
ABILIFY 129 0 16 143
BUSPIRONE HCL 126 0 17 179
CYCLOBENZAPRINE HCL 122 0 R 18 48
LIDODERM 117 37 19 185
GABAPENTIN 116 42 20 4
FUROSEMIDE 112 15 21 8
MORPHINE SULFATE ER 110 26 S2 22 49
METHOCARBAMOL 109 0 R 23 190
OXYCODONE HCL-ACETAMINOPHEN 106 15 S2 24 59
CELEBREX 103 30 25 133
TRAMADOL HCL 100 0 26 40
BUTRANS 92 38 S3 10 27 202
MIRTAZAPINE 87 58 28 71
MELOXICAM 79 0 29 63
ZONISAMIDE 78 16 30 77
VOLTAREN 75 16 31 225
DOXEPIN HCL 74 31 32 181
HYDROXYZINE PAMOATE 74 13 R 32 157
AMITRIPTYLINE HCL 71 16 R 34 106
CYMBALTA 69 0 35 51
METHADONE HCL 67 0 S2 36 83
NUVIGIL 66 0 37 178
SEROQUEL XR 65 14 38 159
VIIBRYD 65 0 38 245
ATENOLOL 64 0 40 54
SINGULAIR 61 0 41 41
LYRICA 59 18 42 49
ONDANSETRON HCL 56 0 43 269
BACLOFEN 54 0 44 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.